Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-04-28 | Mr. Laurence Douglas FinkFounder, CEO & Chairman | -33,90k | 35,61M | Verkauf | 1,05k | 230,52k | -12,82% |
| 2026-04-27 | Mr. Robert Steven KapitoPresident & Member of Board of Directors | -8,74k | 9,23M | Verkauf | 1,06k | 200,29k | -4,18% |
| 2026-02-24 | Mr. Rich KushelSenior MD & Head of the Portfolio Management Group | -2,39k | 2,58M | Verkauf | 1,08k | 136,32k | -1,72% |
| 2026-02-23 | Mr. Stephen CohenSenior MD, Chief Product Officer & Head of Global Product Solutions | -225,00 | 240,65k | Verkauf | 1,07k | 2,00k | -10,10% |
| 2026-02-19 | Mr. Stephen CohenSenior MD, Chief Product Officer & Head of Global Product Solutions | -657,00 | 0,00 | Other Disposition | - | 2,23k | -22,77% |
| 2026-02-13 | Mr. Robert Lawrence GoldsteinSenior MD & COO | -8,63k | 0,00 | Other Disposition | - | 47,80k | -15,30% |
| 2026-02-11 | Mr. Stephen CohenSenior MD, Chief Product Officer & Head of Global Product Solutions | -2,18k | 2,34M | Verkauf | 1,07k | 2,89k | -43,03% |
| 2026-02-10 | Mr. Robert Lawrence GoldsteinSenior MD & COO | -54,19k | 31,09M | Derivative Exercise and Sale | 513,50 - 1,09k | 47,80k | - |
| 2026-02-11 | Mr. Robert Lawrence GoldsteinSenior MD & COO | -5,29k | 5,74M | Verkauf | 1,08k - 1,09k | 47,80k | -9,97% |
| 2026-02-04 | Ms. Margaret L. JohnsonIndependent Member of Board of Directors | -419,00 | 0,00 | Other Disposition | - | 3,01k | -12,23% |
| 2026-01-30 | Mr. Marc David ComercheroMD & CAO | -558,00 | 624,37k | Sale to Issuer | 1,12k | 2,83k | -16,47% |
| 2026-01-30 | Ms. Caroline HellerSenior MD & Global Head of HR | -740,00 | 828,02k | Sale to Issuer | 1,12k | 1,90k | -28,08% |
| 2026-01-30 | Mr. Christopher Joseph MeadeGeneral Counsel & Chief Legal Officer | -3,48k | 3,89M | Sale to Issuer | 1,12k | 10,00k | -25,79% |
| 2026-01-30 | Ms. Rachel LordSenior MD & Head of International | -2,79k | 3,12M | Sale to Issuer | 1,12k | 9,29k | -23,08% |
| 2026-01-30 | Mr. Stephen CohenSenior MD, Chief Product Officer & Head of Global Product Solutions | -2,14k | 2,39M | Sale to Issuer | 1,12k | 5,06k | -29,66% |
| 2026-01-30 | Mr. Martin S. SmallSenior MD, CFO & Global Head of Corporate Strategy | -3,76k | 4,20M | Sale to Issuer | 1,12k | 5,48k | -40,65% |
| 2026-01-30 | Mr. Rich KushelSenior MD & Head of the Portfolio Management Group | -4,19k | 4,68M | Sale to Issuer | 1,12k | 138,71k | -2,93% |
| 2026-01-30 | Mr. Robert Lawrence GoldsteinSenior MD & COO | -6,55k | 7,33M | Sale to Issuer | 1,12k | 53,10k | -10,99% |
| 2026-01-30 | Mr. Robert Steven KapitoPresident & Member of Board of Directors | -10,82k | 12,10M | Sale to Issuer | 1,12k | 209,03k | -4,92% |
| 2026-01-30 | Mr. Laurence Douglas FinkFounder, CEO & Chairman | -14,40k | 16,11M | Sale to Issuer | 1,12k | 264,42k | -5,17% |
| 2026-01-21 | Mr. Rich KushelSenior MD & Head of the Portfolio Management Group | -20,00k | 12,23M | Derivative Exercise and Sale | 513,50 - 1,13k | 134,70k | - |
| 2026-01-16 | Mr. Martin S. SmallSenior MD, CFO & Global Head of Corporate Strategy | -27,05k | 17,79M | Derivative Exercise and Sale | 513,50 - 1,17k | 2,45k | - |
| 2025-12-02 | Mr. Adebayo O. OgunlesiChairman & CEO Global Infrastructure Partners, Senior MD & Member of Board of Director | -28,55k | 0,00 | Other Disposition | - | 1,79M | -1,57% |
| 2025-12-01 | Mr. Martin S. SmallSenior MD, CFO & Global Head of Corporate Strategy | -1,26k | 1,31M | Verkauf | 1,04k | 2,45k | -33,95% |
| 2025-11-13 | Mr. Robert Steven KapitoPresident & Member of Board of Directors | -1.000,00 | 0,00 | Other Disposition | - | 200,29k | -0,50% |
| 2025-10-20 | Ms. Rachel LordSenior MD & Head of International | -12,00k | 13,98M | Verkauf | 1,16k - 1,17k | 4,64k | -72,14% |
| 2025-07-30 | Mr. Rich KushelSenior MD & Head of the Portfolio Management Group | -17,14k | 10,41M | Derivative Exercise and Sale | 513,50 - 1,12k | 136,41k | - |
| 2025-07-25 | Ms. Rachel LordSenior MD & Head of International | -18,04k | 11,04M | Derivative Exercise and Sale | 513,50 - 1,13k | 16,64k | - |
| 2025-07-24 | Mr. Laurence Douglas FinkFounder, CEO & Chairman | -26,88k | 30,21M | Verkauf | 1,12k - 1,13k | 251,70k | -9,65% |
| 2025-07-24 | Mr. Fabrizio FredaIndependent Member of Board of Directors | -4,43k | 4,98M | Verkauf | 1,12k | 2,63k | -62,74% |
| 2025-07-24 | Ms. Susan Lynne WagnerIndependent Member of Board of Directors | -90,00 | 0,00 | Other Disposition | - | 426,88k | -0,02% |
| 2025-07-17 | Mr. Laurence Douglas FinkFounder, CEO & Chairman | -7,62k | 0,00 | Other Disposition | - | 278,58k | -2,66% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
